LDLR and atherosclerosis: To test the effect of argI over-expression on atherosclerosis susceptibility, bone marrow from argI-transgenic (expressing human argI under the control of a CMV promoter) and non-transgenic animals were transplanted into LDL-receptor deficient recipients.